At the INVEST 2025 event in Chicago, poised to occur from April 29-30, Kate Liebelt from Springboard Enterprises takes the spotlight to shed light on vital investment insights in healthcare. As a prelude to the main attraction — a pitch competition focusing on health tech, medtech, and biotech sectors — Liebelt provides a thorough review on how Springboard selects promising startups and helps them flourish.
Springboard’s criteria for evaluating startups hinge on the potential to harness its robust advisory network effectively. They prioritize a strong founding team that marries technical prowess with business acumen and seeks solutions addressing unmet market needs with the capacity to scale. Innovations with unique, often protected, technology stand out, alongside a feasible regulatory strategy pertinent in the heavily-regulated sectors of medtech and biotech. Demonstrable market traction and validation through early partnerships or sales are also crucial indicators of a startup’s viability.
When it comes to pitching, startups often stumble by not crafting a clear, engaging story or underestimating important aspects such as the regulatory challenges and the clarity of their business models. Liebelt stresses the importance of a focused approach—targeting specific problems rather than attempting to tackle too broadly.
Certain areas within the healthcare sector particularly excite Liebelt and her team. They are keen on digital health and women’s health, buoyed by a surge of female-led initiatives. Also, Springboard remains committed to its foundational interests in medical device, pharmaceutical companies, and biotechnology.
The discussion also turns to changing tendencies in investment themes. Impact investing is on the rise, where the emphasis is on societal or health impacts alongside financial returns. Additionally, there’s a marked shift towards startups that promote value-based care models aimed at improving healthcare outcomes while curtailing costs.
Implementing healthcare technologies often begins with pilot programs within hospitals. Liebelt advises ensuring these pilots have clear success metrics aligned with hospital goals, simplicity in integration, and strong internal advocates within the hospital system. These programs, even when successful, might face challenges when transitioning to broader implementation, such as integration complexities, budget limits, and potentially disruptive operational changes.
Further, not all startups fully grasp the intricate processes of hospital procurement and payer adoption, which can significantly delay technology deployment. On a positive note, there has been progress in collaborative approaches between tech providers and hospitals to ensure smoother integrations and ongoing support.
Liebelt also highlights the necessity for startups to deeply understand their operational landscape. This includes insights into regulatory matters, reimbursement strategies, and healthcare provider dynamics. Building robust relationships with healthcare professionals, opinion leaders, and patients is also paramount.
In conclusion, with a thorough grasp of the investment climate, a nuanced understanding of partner engagements, and an emphasis on structured growth strategies, startups stand a better chance of navigating the complex healthcare ecosystem. The upcoming INVEST 2025 event stands as an essential platform for healthcare startups aiming to make significant impacts, offering them a chance to connect with investors, refine their pitches, and understand the intricate dynamics influencing investment and scalability in the healthcare industry.
#Springboard #Enterprises #ExecutiveinResidence #Shares #Advice #Startups
